Huntington National Bank »

Deciphera Pharmaceuticals shares owned by Huntington National Bank

Quarter-by-quarter ownership of Deciphera Pharmaceuticals (DCPH) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Deciphera Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Deciphera Pharmaceuticals held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Deciphera Pharmaceuticals by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.8k 607 16.13
2023-09-30 $7.8k 617 12.72
2023-06-30 $6.4k 455 14.08

More positions owned by Huntington National Bank

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Jp Morgan Chase & Co Common Stock (JPM)
Nvidia Corp Common Stock (NVDA)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IJR)
Alphabet Common Stock (GOOGL)
Ishares Exchange Traded (Principal) (IJH)
Ishares Exchange Traded (Principal) (IVW)
Amazon.com Common Stock (AMZN)
Eli Lilly & Co Common Stock (LLY)
Ishares Exchange Traded (Principal) (IVE)
Visa Common Stock (V)
Exxon Mobil Corp Common Stock (XOM)
Spdr S&p 500 Etf Trust Exchange Traded (Principal) (SPY)

View all positions for Huntington National Bank

Top funds holding Deciphera Pharmaceuticals

Deerfield Management Company
Redmile Group
Vanguard Group
Goldman Sachs Group
Dimensional Fund Advisors
Braidwell
Frazier Life Sciences Management
Assenagon Asset Management
Emerald Advisers
Millennium Management
Emerald Mutual Fund Advisers, Trust
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Deciphera Pharmaceuticals